Results 11 to 20 of about 21,152 (225)
Estimation of Circulating Immune Complexes in patients with Oral Leukoplakia and Oral Submucous Fibrosis: A Case Control Study [PDF]
Journal of Clinical and Diagnostic Research, 2014 Purpose of the Study: The present study was conducted to estimate the serum levels of Circulating Immune Complexes in patients with Oral Leukoplakia ,Oral sub mucous fibrosis and normal subjects and correlate these values with the clinical grades of ...
Maheswari H. +5 more
doaj +1 more source
PLoS ONE, 2021 Tobacco smoking is associated with an increased risk of oral leukoplakia and head and neck cancer. Although it has recently been reported that the establishment of an immunosuppressive microenvironment in oral potentially malignant disorders may lead to ...
Takahiro Yagyuu +3 more
doaj +1 more source
Frequent detection of high human papillomavirus DNA loads in oral potentially malignant disorders [PDF]
, 2016 Human papillomavirus (HPV) is estimated to be the cause of 40-80% of the squamous cell carcinoma of the oropharynx but only of a small fraction of the oral cavity cancers.
ANTONELLI, Guido +10 more
core +1 more source
Critical Reviews in Oral Biology & Medicine, 1995 Leukoplakia has evolved as a clinico-pathologic concept over many years, with the current clinical designation being accepted worldwide. Reflective of the biology of leukoplakia is the concept of cellular atypia and epithelial dysplasia. Adding to a better understanding of leukoplakia in general has been the definition of relevant clinical subsets ...
openaire +2 more sources
Journal of Orofacial Sciences, 2023 Introduction: Chemerin is a multifunctional chemoattractant cytokine, encoded by RARRES2 gene. Its role in oral carcinogenesis is largely unexplored. Study was undertaken to evaluate the role of salivary chemerin as a potential biomarker in the early ...
Karthika Pradeep Susha, Rathy Ravindran
doaj +1 more source
Evaluation of COX-2, EGFR, and p53 as biomarkers of non-dysplastic oral leukoplakias [PDF]
, 2010 [Abstract] Objective. Identify candidate SEBs (surrogate endpoint biomarkers) for premalignant trends in head and neck mucosa. Study design. Study, by qPCR (quantitative real-time polymerase chain reaction), the expression of COX-2, EGFR and p53 in 24 ...
Antón-Aparicio, Luis M. +6 more
core +2 more sources
Clinical periodontal diagnosis
Periodontology 2000, EarlyView., 2023 Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi +5 more
wiley +1 more source
Oral Leukoplakia – Is Biopsy at the Initial Appointment a Must? [PDF]
Journal of Clinical and Diagnostic Research, 2014 Background: Oral leukoplakia is a potentially malignant disorder of the oral cavity. Leukoplakias with chances of undergoing malignant transformation owing to the presence of dysplastic changes may not be clinically distinguishable from leukoplakias ...
Sunil Mutalik +4 more
doaj +1 more source
Immunohistochemical Evaluation of EGFR Expression in Oral Dysplastic and Non-Dysplastic Leukoplakia [PDF]
Journal of Mashhad Dental School, 2023 Background: This study aimed to evaluate the expression of epidermal growth factor receptor (EGFR) in oral leukoplakia with and without dysplasia and normal mucosa by immunohistochemistry.Materials and Methods: In this study, 45 samples of oral ...
Nasrollah Saghravanian +3 more
doaj +1 more source
CO2 lasers in the management of potentially malignant and malignant oral disorders [PDF]
, 2012 The CO2 laser was invented in 1963 by Kumar Patel. Since the early 1970s, CO2 laser has proved to be an effective method of treatment for patients with several types of oral lesions, including early squamous cell carcinoma.
Hamdoon, Z, Hopper, C, Jerjes, W
core +1 more source